Ghana will produce its first locally made vaccine by 2027, NVI says
Read Time:15 Second

The 2027 target builds on a first: in May 2025 the NVI and Atlantic Lifesciences made Ghana’s first biological product, a Snake Venom Anti-Serum, for an estimated 10,000 snakebite victims each year. Procurement of the Ghana-made serum is now under way.

